Duloxetine

Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine

(2010) Evelyn D. Lobo et al.   CLINICAL PHARMACOKINETICS

In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

(2009) Evelyn D Lobo et al.   CLINICAL PHARMACOKINETICS

Population Pharmacokinetics of Orally Administered Duloxetine in Patients

(2009) Evelyn D. Lobo et al.   CLINICAL PHARMACOKINETICS

Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects

(2009) Jill Chappell et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pilot Study of Augmentation With Aripiprazole for Incomplete Response in Late-Life Depression

(2009) Meera Sheffrin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Duloxetine Serum Concentrations and Clinical Effects. Data from a Therapeutic Drug Monitoring (TDM) Survey

(2009) C. Waldschmitt et al.   PHARMACOPSYCHIATRY

Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women

(2008) Evelyn D Lobo et al.   CLINICAL PHARMACOKINETICS

An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects

(2008) A. Patroneva et al.   DRUG METABOLISM AND DISPOSITION

Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial

(2008) S. Englisch et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Influence of Smoking on the Serum Level of Duloxetine

(2008) M. Fric et al.   PHARMACOPSYCHIATRY

Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms

(2007) James M. Russell et al.   DEPRESSION AND ANXIETY

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial

(2007) Moira Rynn et al.   DEPRESSION AND ANXIETY